OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Nephrology and Hypertension is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Membranous nephropathy: current understanding of various causes in light of new target antigens	31
Microbiome modulation as a novel therapeutic approach in chronic kidney disease	28
Depression in dialysis	23
Endothelin receptor antagonists for the treatment of diabetic and nondiabetic chronic kidney disease	23
New insights into muscle function in chronic kidney disease and metabolic acidosis	21
Novel conservative management of chronic kidney disease via dialysis-free interventions	21
Current status of the assessment of sarcopenia, frailty, physical performance and functional status in chronic kidney disease patients	20
Medical nutrition therapy using plant-focused low-protein meal plans for management of chronic kidney disease in diabetes	20
The genetic spectrum of Gitelman(-like) syndromes	18
Disparities in chronic kidney disease-the state of the evidence	18
Ageing, cellular senescence and chronic kidney disease: experimental evidence	18
Novel approach to unpleasant symptom clusters surrounding pruritus in patients with chronic kidney disease and on dialysis therapy	16
Novel approaches to management of hyperkalaemia in kidney transplantation	15
The epidermal growth factor receptor axis and kidney fibrosis	15
Plasma and urine biomarkers in chronic kidney disease: closer to clinical application	15
The « race » correction in estimating glomerular filtration rate: an European point of view	15
Recent advances in dialysis membranes	15
Sodium bicarbonate therapy for acute respiratory acidosis	14
The clinical application of frailty in nephrology and transplantation	14
How common is primary aldosteronism?	14
Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension	14
Precision medicine approach to dialysis including incremental and decremental dialysis regimens	13
Application of dynamic contrast enhanced ultrasound in the assessment of kidney diseases	13
Chimerism and tolerance: past, present and future strategies to prolong renal allograft survival	12
Hypernatremia in the intensive care unit	12

Gut microbiome, parathyroid hormone, and bone	11
Contribution of Th17 cells to tissue injury in hypertension	11
Cardiovascular autonomic nervous system dysfunction in chronic kidney disease and end-stage kidney disease: disruption of the complementary forces	11
New therapeutics for primary hyperoxaluria type 1	11
Diagnosis of amyloid beyond Congo red	11
The impact of advanced glycation end products on bone properties in chronic kidney disease	11
B-cell depletion or belimumab or voclosporin for lupus nephritis?	11
Kidney in the net of acute and long-haul coronavirus disease 2019: a potential role for lipid mediators in causing renal injury and fibrosis	11
Pathogenesis of coronavirus disease 2019-associated kidney injury	11
The potential of artificial intelligence-based applications in kidney pathology	10
Gut–brain–bone marrow axis in hypertension	10
Cystic fibrosis in the kidney: new lessons from impaired renal HCO3− excretion	10
TaleNeprilysin and Neprilysin inhibition in chronic kidney disease	10
Fluid administration strategies for the prevention of contrast-associated acute kidney injury	10
Targeting inflammation in hypertension	10
Cardiovascular disease in children with chronic kidney disease	10
Apolipoprotein L1 and mechanisms of kidney disease susceptibility	10
The quest for cardiovascular disease risk prediction models in patients with nondialysis chronic kidney disease	10
Treatment potential in APOL1-associated nephropathy	10
Novel intestinal dialysis interventions and microbiome modulation to control uremia	9
Lifestyle interventions for preventing and ameliorating CKD in primary and secondary care	9
Mechanisms of leptin-induced endothelial dysfunction	9
Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation	9
SNF472: mechanism of action and results from clinical trials	9
Clinical utility of bone turnover markers in patients with chronic kidney disease	9
Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease	8
Intestinal phosphorus absorption: recent findings in translational and clinical research	8
Novel approaches to hypoglycemia and burnt-out diabetes in chronic kidney disease	8
Coronavirus disease 2019 and kidney injury	8
Neglected analytes in the 24-h urine: ammonium and sulfate	8
Electrolytes disturbances in cancer patients	8
Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one	8
Hypoxia-inducible factor prolyl hydroxylase enzyme inhibitors: ready for primetime?	8
Managing hyperuricemia and gout in chronic kidney disease: a clinical conundrum	8
Healthy and unhealthy aging on kidney structure and function: human studies	7
Lipocalin-2: a novel link between the injured kidney and the bone	7
Revisiting diuretic choice in chronic kidney disease	7
Cellular therapies in kidney transplantation	7
Angiotensin-converting enzyme 2: from a vasoactive peptide to the gatekeeper of a global pandemic	7
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	7
Intravitreal vascular endothelial growth factors hypertension, proteinuria, and renal injury: a concise review	7
Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice	7
Editorial: Novel therapeutic approaches in chronic kidney disease, uremia and kidney transplantation: past, present and future	7
Regulation of renal pendrin activity by aldosterone	7
Redlining has led to increasing rates of nephrolithiasis in minoritized populations: a hypothesis	7
Sex differences in renal electrolyte transport	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	6
Great nephrologists begin with great teachers: update on the nephrology curriculum	6
Maximizing opportunities for kidney transplantation in older adults	6
Climate change and kidney stones	6

Communication principles and practices for making shared decisions about renal replacement therapy: a review of the literature	6
Indications for and results of renal autotransplantation	6
Complement and kidney disease, new insights	6
Novel management of diabetes in kidney transplantation	6
Novel approaches to management of hypertension	6
Role of deceased donor kidney procurement biopsies in organ allocation	6
Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease	6
Hypertension in Pregnancy: What We Now Know	6
How to assess quality of life in persons with chronic kidney disease	6
WNK1 in the kidney	6
Gut–kidney axis in oxalate homeostasis	6
Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders	6
Collapsing glomerulopathy: unraveling varied pathogeneses	5
Seven suggestions for successful SGLT2i use in glomerular disease - a standalone CKD therapy?	5
Spatial transcriptomics and the kidney	5
Pruritus in chronic kidney disease	5
Nutritional and dietary interventions to prolong renal allograft survival after kidney transplantation	5
Novel monitoring of renal function and medication levels in saliva and capillary blood of patients with kidney disease	5
How to inhibit transforming growth factor beta safely in diabetic kidney disease	5
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	5
Interaction between sodium-glucose co-transporter 2 and the sympathetic nervous system	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5
Novel agents for treating IgA nephropathy	5
Challenges in communication, prognostication and dialysis decision-making in the COVID-19 pandemic: implications for interdisciplinary care during crisis settings	5
Research progress of sirtuins in renal and cardiovascular diseases	5
Fibroblast growth factor 23, klotho and heparin	5
Updated management for antibody-mediated rejection: opportunity to prolong kidney allograft survival	5
Novel therapeutic and diagnostic approaches for preeclampsia	5
Uromodulin: more than a marker for chronic kidney disease progression	5